Tag: Diabetic ketoacidosis

Hyperglycemia, or high blood sugar, affects 22% to 46% of non-critically ill hospitalized patients [1.10.2, 1.10.4]. This article details what insulin is used for in hospitals to manage this and other critical conditions, ensuring patient stability and safety.

According to the National Institute on Drug Abuse, over 2.5 million Americans aged 12 or older used methamphetamine in the past year, a process that can emit a strong chemical odor. While an acetone-like scent can be a sign of illicit drug activity, it can also point to serious and life-threatening medical conditions, making it critical to understand what drug smells like nail polish remover and what other possibilities exist.

Over 78% of people taking alpha-glucosidase inhibitors may experience gastrointestinal side effects, highlighting the importance of proper patient selection. Before initiating treatment, healthcare providers and patients must understand **what are the contraindications to therapy with alpha-glucosidase inhibitors** to avoid serious complications and ensure treatment efficacy.

Over 26 million adults take empagliflozin, the active ingredient in Jardiance, for conditions like Type 2 diabetes, heart failure, and chronic kidney disease. To ensure its effectiveness and avoid adverse effects, it is crucial to understand what to avoid while taking Jardiance, from specific medications to certain dietary choices.

According to a study reported in the Italian Journal of Pediatrics, iatrogenic severe hyperglycemia (ISH) caused by glucose-containing IV solutions is a potentially fatal treatment error. This highlights the significant risks associated with the scenario of a patient's blood sugar not decreasing after receiving a dextrose infusion.

In late 2024, the FDA's advisory committee delivered an 11-3 vote against approving sotagliflozin (brand name Zynquista) for type 1 diabetes patients with chronic kidney disease. This decision marked the second major setback for the drug in this indication, as the FDA rejected sotagliflozin once again over persistent and unmitigated concerns about a heightened risk of diabetic ketoacidosis (DKA).

Over 5% of people with type 1 diabetes will experience diabetic ketoacidosis (DKA) at some point, a serious condition that causes a tell-tale fruity breath. Addressing the search query 'what drug makes you smell sweet?' requires looking beyond benign causes and understanding that this odor is often a critical warning sign of metabolic imbalance or substance misuse.